Lv34
398 积分 2024-08-02 加入
Poziotinib treatment in patients with HER2-positive advanced breast cancer who have received prior anti-HER2 regimens
14天前
已完结
Antibody drug conjugates in non-small cell lung cancer: An emerging therapeutic approach
17天前
已完结
Safety, pharmacokinetics and pharmacodynamics of SHR-1703, an innovative long-acting anti-interleukin-5 monoclonal antibody, in healthy subjects: a randomized, double-blind, dose-escalation, placebo-controlled phase I study
2个月前
已完结
The potential of monoclonal antibodies for colorectal cancer therapy
3个月前
已完结
Immunotherapy for colorectal cancer: Rational strategies and novel therapeutic progress
3个月前
已完结
A Phase I Clinical Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of GB221 Injection and Trastuzumab (Herceptin®) in Healthy Chinese Adults
3个月前
已完结
A randomized, crossover, phase I clinical study to evaluate bioequivalence and safety of tofacitinib and Xeljanz® in Chinese healthy subjects
3个月前
已完结
皖公网安备34019202002308
